Dissolution variability: comparison of commercial dosage forms with US Pharmacopeia Lot P Prednisone reference standard tablets--a technical note.
作者信息
Nithyanandan Pallavi, Hauck Walter W, Munoz Jimmy, Deng Gang, Brown William, Manning Ronald G, Wahab Samir
机构信息
United States Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790, USA.
出版信息
AAPS PharmSciTech. 2008;9(1):238-42. doi: 10.1208/s12249-008-9034-z. Epub 2008 Feb 8.
Abstract
摘要
相似文献
1
Dissolution variability: comparison of commercial dosage forms with US Pharmacopeia Lot P Prednisone reference standard tablets--a technical note.溶出度变异性：市售剂型与美国药典批次P泼尼松参比标准片的比较——技术说明
AAPS PharmSciTech. 2008;9(1):238-42. doi: 10.1208/s12249-008-9034-z. Epub 2008 Feb 8.
2
Establishing new acceptance limits for dissolution performance verification of USPC apparatus 1 and 2 using USPC prednisone tablets reference standard.使用美国药典泼尼松片参比标准，为美国药典仪器 1 和 2 的溶出性能验证建立新的可接受限度。
Pharm Res. 2011 Mar;28(3):505-16. doi: 10.1007/s11095-010-0295-3. Epub 2010 Oct 16.
3
The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.美国药典性能验证测试，第一部分：美国药典批次P泼尼松片：影响溶出度差异的质量属性和实验变量
Pharm Res. 2008 May;25(5):1100-9. doi: 10.1007/s11095-007-9498-7. Epub 2008 Jan 3.
4
The USP Performance Verification Test, Part II: collaborative study of USP's Lot P Prednisone Tablets.美国药典性能验证测试，第二部分：美国药典P批次泼尼松片的协作研究
Pharm Res. 2008 May;25(5):1110-5. doi: 10.1007/s11095-007-9482-2. Epub 2008 Jan 3.
5
Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.泼尼松片采用装置2的美国药典溶出度试验的协作研究。
J Pharm Sci. 1984 May;73(5):670-6. doi: 10.1002/jps.2600730520.
6
Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.在 USP 溶解试验仪 2 中，使用弓状光纤探头使泼尼松片剂溶解。
J Pharm Sci. 2013 Aug;102(8):2718-29. doi: 10.1002/jps.23651. Epub 2013 Jul 16.
7
Vibration effects of lab equipment on dissolution testing with USP paddle method.实验室设备振动对 USP 桨法溶出度测试的影响。
J Pharm Sci. 2010 Jan;99(1):403-12. doi: 10.1002/jps.21847.
8
Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution.美国药典泼尼松校准片的溶出度：搅拌条件和粒度分布的影响
J Pharm Biomed Anal. 2003 Apr 10;31(6):1129-43. doi: 10.1016/s0731-7085(02)00732-x.
9
Equivalence studies for complex active ingredients and dosage forms.复杂活性成分和剂型的等效性研究。
AAPS J. 2005 Nov 17;7(4):E786-812. doi: 10.1208/aapsj070477.
10
The development of USP dissolution and drug release standards.美国药典溶出度和药物释放标准的发展。
Pharm Res. 1990 Oct;7(10):983-7. doi: 10.1023/a:1015922629207.
引用本文的文献
1
Response to the Commentary from A Dissolution Working Group on "The Effect of Sampling Cannula on In Vitro Dissolution Testing with USP Paddle Method": Clarifications and Opportunities for Engagement.对溶出度工作组关于“取样插管对采用美国药典桨法进行的体外溶出度测试的影响”的评论的回应：澄清与参与机会
AAPS J. 2025 Jul 16;27(5):120. doi: 10.1208/s12248-025-01107-9.
2
Effects of Glass Bead Size on Dissolution Profiles in Flow-through Dissolution Systems (USP 4).玻璃珠粒径对流动溶出系统（USP4）中溶出曲线的影响。
AAPS PharmSciTech. 2024 Oct 22;25(8):251. doi: 10.1208/s12249-024-02972-x.
本文引用的文献
1
The USP Performance Verification Test, Part II: collaborative study of USP's Lot P Prednisone Tablets.美国药典性能验证测试，第二部分：美国药典P批次泼尼松片的协作研究
Pharm Res. 2008 May;25(5):1110-5. doi: 10.1007/s11095-007-9482-2. Epub 2008 Jan 3.
2
The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.美国药典性能验证测试，第一部分：美国药典批次P泼尼松片：影响溶出度差异的质量属性和实验变量
Pharm Res. 2008 May;25(5):1100-9. doi: 10.1007/s11095-007-9498-7. Epub 2008 Jan 3.
3
Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations.盐酸普萘洛尔和酒石酸美托洛尔片剂配方的放大生产对溶出度和生物利用度的影响。
AAPS PharmSciTech. 2000 Jun 17;1(2):E14. doi: 10.1208/pt010214.
4
Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.药物溶出度测试中的典型变异性：使用美国药典（USP）和美国食品药品监督管理局（FDA）校准片以及一种市售药物（格列本脲）产品的研究
Eur J Pharm Sci. 1999 Feb;7(3):249-58. doi: 10.1016/s0928-0987(98)00034-7.
5
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets.确定影响盐酸普萘洛尔片体外溶出度和体内生物利用度的制剂和生产变量。
Pharm Dev Technol. 1998 Nov;3(4):535-47. doi: 10.3109/10837459809028636.
6
The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.剂型和工艺变更对吡罗昔康胶囊体外溶出度及生物等效性的影响。
Pharm Dev Technol. 1998 Nov;3(4):443-52. doi: 10.3109/10837459809028625.
7
The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.颗粒内和颗粒外微晶纤维素在片剂溶出中的作用。
Pharm Dev Technol. 1996 Dec;1(4):343-55. doi: 10.3109/10837459609031429.
Zotero 插件